Advanced Search

Medicare Compliance & Reimbursement

Reader Question:

Carrier LCD Determines Whether to Expect Payment for J7325

Published on Sun Nov 11, 2012

Question: One of our Medicare patients receives knee injections for her arthritis. She's interested in trying Synvisc, but I don't see that on our Medicare fee schedule. When I called the carrier to ask about it, the representative told me that they don't publish a list of all covered J codes. She told me to send in the claim and see if it gets paid. I'd like to avoid any write-offs or denials. What's your advice?Answer: Some Medicare carriers (such as Trailblazer) do cover the code in question, J7325 (Hyaluronan or derivative, Synvisc or Synvisc-One, for intra-articular injection, 1 mg). A quick check of the local coverage determinations (LCDs) for the carrier in Louisiana (Novitas Solutions) shows that they do have one regarding J7325 use, effective August 13, 2012. That LCD indicates that J7325 is covered under certain conditions. For more information, please view the LCD online at www.novitas-solutions.com/policy/jh/l32737-r1.htmlWhen you [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All